New adult ADHD drug receives FDA approval - United Press International

New adult ADHD drug receives FDA approval
United Press International - 19 hours ago
The new drug, Vyvanse, has been marketed in the United States since July 2007 for the treatment of ADHD in children 6-12 years of age. …

Find Out More:

Books:

Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
ADHD: Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults
Taking Charge of ADHD: The Complete, Authoritative Guide for Parents (Revised Edition)
ADHD Adult
Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders

April 24th, 2008
Vyvanse

Truncated Domes

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Autism Nutrition and Chelation

Natural ADHD Treatments

Golfshop

Discuss the topics raised by this article on the Myomancy Forum.

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism